Authors
Loading...
This retrospective case series defines features of cutaneous toxicity in patients treated with enfortumab vedotin, suggesting a framework for identification.
Repetto et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: